Management of hypovitaminosis D in patients with primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 37, Issue 5, 2014, Pages 467-471

  Rathi, M S ^a   Gonzalez, S ^a   Wright, D ^a   Ellis, N R ^a   Peacey, S R ^a  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Hypovitaminosis D; Primary hyperparathyroidism; Vitamin D deficiency; Vitamin D insufficiency

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM PHOSPHATE; COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN D; BIOLOGICAL MARKER; CALCIFEDIOL; PTH PROTEIN, HUMAN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE TURNOVER; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; FRACTURE; HUMAN; HYPERCALCEMIA; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; TREATMENT DURATION; VERY ELDERLY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; SECONDARY CARE CENTER; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCIFEDIOL; CALCIUM; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; GREAT BRITAIN; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; SECONDARY CARE CENTERS; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 84900534592     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0056-y     Document Type: Article

References (22)

1. Fraser WD (2009) Hyperparathyroidism. Lancet 374:145-158
2. Lundgren E, Hagström EG, Lundin J et al (2002) Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 26:931-936 (Pubitemid 36920289)
3. Moosgaard B, Vestergaard P, Heickendorff L et al (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol 63:506-513 (Pubitemid 41626744)
4. Silverberg SJ, Shane E, Dempster DW et al (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561-567
5. Clements MR, Davies M, Hayes ME et al (1992) The role of 1, 25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (Oxf) 137:17-27
6. Clements MR, Davies M, Fraser DR et al (1987) Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond) 73:659-664 (Pubitemid 18013299)
7. Nordenstrom E, Westerdahl J, Lindergard B et al (2002) Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 26:1463-1467 (Pubitemid 36920206)
8. Rao DS, Honasoge M, Divine GW et al (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054-1058 (Pubitemid 32269349)
9. Rao DS, Agarwal G, Talpos GB et al (2002) Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 17:N75-N80
10. Lumb GA, Stanbury SW (1974) Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 56:833-839
11. Silverberg SJ (2007) Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res 22(S2):100-104
12. Kantorovich V, Gacad M, Seeger LL, Adams JS (2000) Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 85:3541-3543
13. Carnevale V, Manfredi G, Romagnoli E et al (2004) Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol 60:81-86 (Pubitemid 38183502)
14. Yamashita H, Noguchi S, Uchno S et al (2002) Vitamin D status in Japanese patients with hyperparathyroidism. World J Surg 26:937-941
15. Grey A, Lucas J, Horne A et al (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90:2122-2126 (Pubitemid 40586249)
16. Grubbs EG, Rafeeq S, Jimenez C et al (2008) Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 144:852-858
17. Tucci JR (2009) Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol 161:189-193
18. Isidro ML, Ruano B (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 36:305-310
19. IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC, pp 260-262
20. Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911-1930
21. Eastell R, Arnold A, Brandi ML et al (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2:340-350
22. Awumey EM, Mitra DA, Hollis BW et al (1998) Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 83:169-173 (Pubitemid 28498330)